CVR: 43007068
DKK -1,687,751
Gross profit
Net result: DKK -4,355,625
John Sørensen Haurum, Stine Helene Falsig Petersen
5 more
CVR · view ownership and management
Director registered: John Sørensen Haurum
CVR · 28/08/2025
View the full event history
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766.
Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -1.7 mio. | -4.4 mio. | 6.8 mio. | -15.4 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | -4.2 mio. | -6.8 mio. | 11 mio. | -11 mio. | 4 | |
| 202301/01/2023 – 31/12/2023 | -2.7 mio. | -3.5 mio. | 10.8 mio. | -4.2 mio. | 2 | |
| 202221/01/2022 – 31/12/2022 | -398 t. | -797 t. | 3.6 mio. | -757 t. | 1 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationSolid Therapeutics ApS was founded on 21 January 2022.
Solid Therapeutics ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
The owners of Solid Therapeutics ApS include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen.
In 2025, Solid Therapeutics ApS reported a gross profit of DKK -1,687,751.
The management of Solid Therapeutics ApS consists of John Sørensen Haurum.
Solid Therapeutics ApS is located at Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
Solid Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -1,687,751, and the net result was DKK -4,355,625.
As of August 28, 2025, John Sørensen Haurum is registered as adm. dir. of Solid Therapeutics ApS.
As of August 28, 2025, Anne Mette Hyldgaard Trauelsen has stepped down as adm. dir. of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,213,656, and the net result was DKK -6,758,207.
Solid Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -2,738,806, and the net result was DKK -3,483,115.
As of December 7, 2023, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Solid Therapeutics ApS.
Solid Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -397,812, and the net result was DKK -796,818.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as adm. dir. of Solid Therapeutics ApS.
As of February 1, 2023, John Sørensen Haurum has stepped down as director of Solid Therapeutics ApS.
As of February 1, 2023, Stine Helene Falsig Petersen is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 1, 2023, Anne Mette Hyldgaard Trauelsen is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of February 1, 2023, is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of February 21, 2022, John Sørensen Haurum is registered as director of Solid Therapeutics ApS.
As of February 21, 2022, Claus Haase has stepped down as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Thue Walter Schwartz has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase has joined the board of directors of Solid Therapeutics ApS.
As of January 21, 2022, Claus Haase is registered as director of Solid Therapeutics ApS.
As of January 21, 2022, John Sørensen Haurum is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
As of January 21, 2022, Receptor Holding ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Frimurer Holdings ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 20%.
As of January 21, 2022, Haase Invest ApS is registered as an owner of Solid Therapeutics ApS with an ownership share of 10%.
Solid Therapeutics ApS was founded on January 21, 2022.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
